The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hogan Linda C. since 2016.
The trader's CIK number is 1639972.
At the time of the last reporting, Hogan Linda C. was the Head, Bus. Dev. and Strategy of Colucid Pharmaceuticals, Inc.. (stock ticker symbol CLCD).
Also see all insider trading activities at Colucid Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | CLCD | 0 | $0 | 2,580 | $90,652 | 2,580 | $23,014 |
| 2016 | CLCD | 0 | $0 | 53,898 | $1,133,343 | 53,898 | $382,222 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-01-03 | CLCD | Option Ex | 718 | 6.75 | 4,846 |
| 2017-01-05 | CLCD | Sale | 1,677 | 34.52 | 57,891 |
| 2017-01-04 | CLCD | Sale | 185 | 36.40 | 6,734 |
| 2017-01-05 | CLCD | Option Ex | 1,677 | 10.00 | 16,770 |
| 2017-01-03 | CLCD | Sale | 718 | 36.25 | 26,027 |
| 2017-01-04 | CLCD | Option Ex | 185 | 7.56 | 1,398 |
| 2016-11-04 | CLCD | Sale | 185 | 28.95 | 5,355 |
| 2016-11-07 | CLCD | Option Ex | 1,677 | 10.00 | 16,770 |
| 2016-11-07 | CLCD | Sale | 1,677 | 28.52 | 47,829 |
| 2016-11-04 | CLCD | Option Ex | 185 | 7.56 | 1,398 |
| 2016-11-01 | CLCD | Option Ex | 719 | 6.75 | 4,853 |
| 2016-11-01 | CLCD | Sale | 719 | 30.00 | 21,570 |
| 2016-10-05 | CLCD | Sale | 1,677 | 37.08 | 62,183 |
| 2016-10-04 | CLCD | Sale | 185 | 36.41 | 6,735 |
| 2016-10-05 | CLCD | Option Ex | 1,677 | 10.00 | 16,770 |
| 2016-10-03 | CLCD | Sale | 719 | 37.74 | 27,135 |
| 2016-10-04 | CLCD | Option Ex | 185 | 7.56 | 1,398 |
| 2016-10-03 | CLCD | Option Ex | 719 | 6.75 | 4,853 |
| 2016-09-06 | CLCD | Option Ex | 48,736 | 6.90 | 336,180 |
| 2016-09-06 | CLCD | Sale | 48,736 | 19.75 | 962,536 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hogan Linda C. (Head, Bus. Dev. and Strategy of Colucid Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.